To assess the efficacy of Aabresham (Bombyx mori) for the prevention of atherosclerosis.
of oxidative stress to some extent and Unani drugs have demonstrated positive effects in modifying risk factors for CVDs. Some of the Unani drugs have shown hypolipidemic, anti-atherogenic, antioxidant and antiinflammatory effects. One of them is Aabresham (Bombyx mori), which is mentioned as Mufarrah wa Muqawwie Qalb (Cardiotonic), Mufattite sudud (Deobsruent) Mulattif (Demulcent), Munaqqie balgham wa sauda (Purgative) and Musaffi dam(Blood purifier) in classical text of Unani medicine. 7,8.9.10,11 Thus, the present study is conducted to evaluate the protective effect of Aabresham (Bombyx mori) against atherosclerosis using modern day tools. If the study found to succeed in its objective, it will help to fill the gap in the knowledge to some extent.
Subjects and Methods:
Study was conducted after obtaining the ethical clearance by the Institutional Ethical Committee of National Institute of Unani Medicine, Bangalore, India (Reg. No. 07_U006_51360). Inclusion Criteria: Patients of either sex, age group 35-60 years, B.P ≥ 140/90 mm Hg or on antihypertensive medication, Serum triglyceride (150-499 mg/dl) and Low density lipoprotein (100-189 mg/dl). 12 Exclusion Criteria: Patients below the age of 35 years and above 60 years, bleeding disorders and uncontrolled Blood Pressure. Selection of subjects: Patients were inquired about their demographic profile and socioeconomic status. For socioeconomic status, Kuppuswamy"s socioeconomic scale was used (Modified 2014, Jan). 13 All the patients were interrogated about their chief complaints especially regarding palpitation, headache, dizziness, breathlessness, chest pain, fatigue, insomnia, nervousness, dyspnoea & epistaxis with duration. Detailed history of any organic disease (especially cardiovascular diseases and Diabetes), family history, personal, social, any treatment and gynaecological or obstetrical history was also taken. General physical examination and a careful systemic examination of cardiovascular system, respiratory system, gastrointestinal system, renal system and nervous system were carried out to look for any finding or other serious illness. Any positive finding or regression or progression of symptoms was recorded in the Case record form designed in accordance to the objectives of the study. Investigations: Certain investigations were carried out to exclude the patients, to assess the efficacy and to establish the safety of test drug. Haemoglobin%, Total Leucocytes count, Differential Leucocyte count, Bleeding time, Clotting time, Erythrocyte Sedimentation Rate, Renal function test, Liver Function test, Lipid peroxidation test (MDA concentration assessment by Ohkawa et al 1979), lipid profile, random blood sugar and haematocrit were done in every case before and after intervention. Method of preparation and mode of administration of test and control drugs Test drug Aabresham (Bombyx mori) and control drug Atorvastatin were provided by National Institute of Unani Medicine. Proper identification of the drug was done by chief pharmacist, National Institute of Unani Medicine, to ensure their originality and authenticity. The drug was cleaned to remove any unwanted material and impurities. Test group was treated with six gm of Aabresham (Bombyx mori) in the morning, empty stomach for two months as decoction. While Control group was treated with Atorvastatin ten mg orally in the evening for the same period of time. Follow up: Patients were kept under strict observation and advised to come every 15 th day to the hospital and were asked about the progression or regression in their symptoms, and subjected to assess the clinical findings. Concomitant treatment was not allowed during the study in both groups. Efficacy assessment: The assessment of the efficacy in both the groups was based on objective and subjective parameters. Assessment of objective parameters like blood pressure measurement was done on every15 th day while, lipid profile, haematocrit and MDA assessment was done before and after intervention. Subjective parameters like palpitation, breathlessness, headache and chest pain were assessed by an arbitrary grading, as these parameters differ in severity from patient to patient. Before starting treatment, baseline observations were recorded in the case report form and any worsening or improvement in the parameters was noted down at every visit of follow up till the end of the treatment. 
Results &Discussion:
Maximum numbers of subjects studied were females under the age group of 51-60 years. Most of the females in this age group had attained menopause. Estrogen plays a protective role against atherosclerosis. The risk of development of CVDs increases 3.4 times after menopause. These observations are similar to that of J. C. Witteman et al (1989) .
14 Nearly 78% (39) of study subjects were non vegetarian (mixed diet) and 22% (11) were vegetarian. This study corresponds to the study of Manish Verma and group (2015) 15 , whose results specified that the mean total cholesterol levels in their study was significantly increased in non-vegetarians that raised the risk for overweight and obesity. Vegetarian diet is comprised of fibres which increase bile-acid binding, faecal sterol excretion, and fermentation of soluble fibres that produce shortchain fatty acids which inhibit hepatic cholesterol synthesis. As the study population is mainly comprised of females therefore, 86% (43) subjects found to be non smokers, whereas 14% (7) were smokers. Cigarette smoking may increase the risk of CVD by promoting atherosclerosis progression and other triggering factors like changing in homeostasis. Both active smoking and exposure to smoke are associated with the progression of atherosclerosis. The outcome of our observation are quite similar to that of George Howard et al (1998) 16 where, although most of the participants were females yet developed atherosclerosis as they were passively exposed to smoking. 36%(18) of subjects virtually belonged to upper lower class (IV), 24% (12) to upper middle class(II), 20%(10) from lower middle class (III), 16% (8) upper class I and 4% (two) from lower class(V). CVD risk factors among the urban poor and middle class are rapidly increasing in India. The probable reason for this is an "aspiration effect" which has behavioural consequences among the rich people in India. The aspiration to emulate the western society leads to improved awareness of the preventive measures to tackle the raised CVD risk in these groups. By contrast, higher levels of tobacco use, obesity or overweight and hypertension are now associated with lower levels of education and income in India. Our study coincides with the results of P. Jeemon and K. S. Reddy. 17 Almost 12% (24) subjects under study were found to had a positive family history of cardiovascular diseases and the remaining 72% (36) subjects had no family history of CVD. Our study demonstrated the same results as by Arvind K et al 18 suggested that family history may have a "dose-dependent" effect, where individuals with more robust family histories of CHD are at greater risk of developing CVDs. It had a significant increase in incidence and progression of coronary artery calcification. Our study comprised of 32% (16) pre-obese subjects, 24% (12) obese class I, 22% (11) obese class II, 8% (4) obese class III. Along with this 76% (38) of subjects spend a sedentary life style, 16% (8) engaged in moderate physical activity and 8% (4) mild physical activity. Sedentary lifestyle increases all causes of mortality, double the risk of cardiovascular diseases, obesity, high blood pressure & lipid disorders. An increased risk of death, CVD, Coronary heart disease and ischemic stroke was observed in pre obese subjects (BMI> 24.9), studied by Yu Chen et al (2013) which resembles with the observations made by us. 19, 20 (Table No. 1) While assessing the subjective parameters, our observations showed statistically a significant reduction in breathlessness, palpitation, headache and chest pain in both the groups, after intervention as compared to before intervention(p<0.001). Whereas clinically Test group showed highly significant reduction in breathlessness, palpitation, headache and chest pain on day 60 th, with respect to 0 day. (Fig No.1 
Blood pressure
In present study both the groups showed highly significant reduction in systolic and diastolic blood pressure after treatment as compared to before treatment with p <0.01. The intra group comparison exhibited that Mean ± SEM(Standard error of mean) score difference in test group for Systolic blood pressure(SBP) was 25.733 and for Diastolic blood pressure (DBP) was 11.433 as compared to control group which was 17.200 for SBP and 6.950 for DBP on day 60 th with respect to day 0. (Table No. 2) The above observations showed that there is a significant reduction in systolic and diastolic blood pressure in test group with p<0.001, as compared to control group after intervention with respect to before intervention.
Serum cholesterol
Clinically and statistically both the drugs reduced the total serum cholesterol level to a highly significantly level on day 60 th with respect to day 0, p<0.001. (Table No. 2) Serum Triglycerides Clinically both the drugs were found to be almost equally effective in reducing serum triglycerides level with p=0.539 after intervention. (Table No. The intra and inter group comparison indicated that there is a marked significant reduction in LDL-C level in both the groups, p<0.001 after intervention in comparison to baseline values. Therefore, both the drugs found to be equally effective in reducing LDL-C on day 60 th with respect to day 0. (Table No. 
2) High density lipoprotein-Cholesterol (HDL-C)
The statistical assessment showed no difference in the increment of HDL-C after invention with p=0.719 compared to baseline values. Hence, none of the drug is found to be statistically efficient in increasing HDL-C.
MDA (Malonedialdehyde) concentration
The Mean ± SEM MDA concentration difference in test group was found as 1.670 on day 60 th with respect to 0 day. The Mean ± SEM MDA concentration difference in control group was 1.387 on 60 th day in comparison to day 0. Statistically both the drugs imparted significant reduction in MDA concentration after intervention with respect to baseline values, p<0.001. (Table No. 2)MDA is a marker of oxidative stress and in many studies; it showed highly significant relation with coronary artery diseases revealing the interrelation between the oxidative stress and atherosclerosis. The MDA, a carbonyl group produced during lipid peroxidation, is used widely in determining oxidative stress. Decrease in MDA concentration indicates decrease in lipid peroxidation, which is a suggestive of decrease in chronic inflammatory changes and improved Nitric oxide (NO) functioning.
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Haematocrit
None of the drug is found to be statistically efficient in decreasing Haematocrit values,with p= 0.973 after intervention.
Fig 2 Effect of drug on BP, Serum Cholesterol, Triglycerides, LDL, HDL& MDA in Atherosclerosis risk subjects (Mean ± SEM)
Safety Parameters
No adverse effects were observed during and after the study in both the groups. However, the Mean ± SEM score of blood urea in test group was 26.90±7.29 on day 0 that increased to 30.99±7.15 on day 60 th , p =0.032. Clinically no adverse reaction was observed but statistically significant increment was shown in blood urea values after intervention. Cocoon of Bombyx mori is mainly comprised of protein (12-16%). The probable reason for the increased blood urea might be due to the high protein intake, particularly sulfur containing amino acids (Methionine and Cystine) that increase endogenous acid production, causing a parallel increase in ammonia excretion. 22 Findings of our study showed significant reduction in breathlessness, palpitation, chest pain, blood pressure, serum cholesterol, LDL, MDA concentration on 60 th day as compared to 0 day in test group. The pathogenesis of atherosclerosis involves two process viz oxidative stress and formation of atherosclerotic plaque. Previous studies showed that Bombyx mori(B.mori) possess antioxidant, anti-arrhythmic, antithrombotic, anti inflammatory, cholesterol-lowering, antihypertensive and anti-platelet activities in animal models. These activities are mainly contributed to the essential fatty acids, flavonoids, and essential amino acids present in B.mori. The essential fatty acid, α-linolenic acid (omega-3 fatty acid), possess antiarrhythmic, anti-thrombotic and anti inflammatory activities. Through an inefficient enzymatic process of desaturation (the rate of conversion is less than 1 percent), Alpha linolenic acid (ALA) produces eicosapentaenoic acid (20 carbons) and docosahexaenoic acid (22 carbons), precursors to a group of eicosanoids (prostaglandins, thromboxanes, and leukotrienes) that are anti-inflammatory, antithrombotic, anti-arrhythmic, and vasodilator. 23 The flavonoids found in the cocoon of B. mori comprised of three quercetin glycosides. These quercetin compounds shown to have potent anti oxidant activity as they reduce lipid peroxidation by scavenging free radicals. A part from anti oxidant, these quercetins have anti-inflammatory, anti atherogenic, anti coagulation and anti hypertensive effects too. 24, 25 These compounds also inhibit smooth muscle cells proliferation, migration and improve vascular function. Flavonoids reduce lipid peroxidation by scavenging ROS, chelation of transition metal ions along with reducing macrophage oxidative stress by inhibition of cellular oxygenases or by activating cellular antioxidants such as glutathione system. 26 Various pharmacological studies isolated 17 amino acids from the cocoon of B. mori including histidine, lysine, aspartic acid, arginine, glutamic acid, threonine, cystine, proline, tyrosine, tryptophan, valine, phenylalanine, leucine, isoleucine, glycine, alanine and serine but majority of the amino acids are comprised of Glycine, Alanine and Serine (82%). 27, 28 They aid different biological processes and played a versatile role in the prevention of atherosclerosis. Amino acids are the inhibitors of lipid peroxidation, scavengers of free radicals and chelate the transition metal ions. Sometimes they indirectly help in the reduction of ROS by assisting other anti oxidants like glutathione (an endogenous anti oxidant) that regulates Nitric oxide cycle and reduces ROS. Hence, protects against free radical mediated oxidative damage. 29 Glycine has been found to exert anti inflammatory, immunomodulatory, cytoprotective, platelet stabilising and antiangiogenic effects in rodent studies. Recent studies demonstrated that pre administration of glycine reduces the infarct size by 21%, which increases ventricular ejection fraction and fractional shortening. It increase endothelial Nitric oxide generation coupled with a decrease in superoxide production. Glycine exerts an anti inflammatory effect on coronary arterial cells exposed to tumour necrosis factor-α in vitro. 30 Alanine, another important amino acid, is a precursor for the synthesis of the dipeptide-carnosine. Carnosine also has a substantial antioxidant activity as it is an electron donor, preventing lipid peroxidation and interacts with superoxide to stabilize it, chelate copper and iron and prevents the production of hydroxyl radicals. Carnosine copper complexes possess superoxide dismutase activity. Furthermore carnosine binds covalently to reactive degradation products of peroxidised lipids, thus prevent them from reacting with other cellular targets. 31 Serine participates in the biosynthesis of another amino acid-Cystine. Methionine and Cystine have shown a strong positive effect on scavenging of 2, 2-diphenyl-1-picrylhydrazyl (DPPH) and hydrogen peroxide ( H 2 O 2 ) in vitro. 32 Cystine, Methionine, Glutamic acid and Glycine are required for the generation of glutathione. In cholesterol metabolism, Hydroxymethyl glutaryl co-enzyme A (HMG-CoA) reductase is activated by Glutathione. Cholesterol synthesis is suppressed by higher hepatic Glutathione content. These amino acids therefore, lowers the cholesterol. 33 Another essential amino acid found in B.mori is Arginine. It also contributes to the production of Nitric oxide (natural vasodilator that helps to maintain normal blood flow in the vessels). Thus reduces blood pressure. 34 Hursen, M in his study found that Arginine reduces cholesterol level in blood without effecting HDL. 35 Carnitine (dipeptide made of lysine and methionine) transports long chain fatty acids to mitochondria where they are consumed for energy production and lowers the cholesterol in blood. 30 Taurine (organic compound formed by methionine and cystine) is important to heart muscles. The heart rhythm is regulated by potassium and calcium. They cause the tension and relaxation of the heart musculature. Taurine regulates the supply of potassium and calcium to the heart and can thereby eliminate cardiac arrhythmias. Furthermore, taurine lowers the cholesterol level as it stimulates the flow of bile. Apart from this, it also inhibits the clumping of the blood platelets. 36, 37 Taurine acts on nerves and reduces the signaling that decrease the resistance to blood flow and lowers the BP. 38 It is found experimentally that B.mori also possess vascular anti-oxidant enzymes -SOD (Superoxide dismutases), Catalase and glutathione peroxidases. SOD, dismutate O 2 •− to H 2 O 2 and oxygen. Catalase, catalyzes the decomposition of H 2 O 2 to water and oxygen. Glutathione peroxidases utilize glutathione to reduce H 2 O 2 and fatty acyl peroxides to water and lipid alcohols respectively. 39 According to Unani medicine atherosclerosis is a type of Marz-e-majari(disease of vessels) in which Sharain (arteries) become narrow or obstructed by sudda(obstruction). It is caused by raddi akhlat(morbid matter) produced as a defect of hazme saani (vascular digestion). These raddi akhlat can be akhlat-eGhaleeza (Vicid Humor) or akhlat-e-Luzuja, (Sticky Humor). As a result of which the vessels supplying the respective organs (like heart, brain, kidney etc.) also get affected and produces symptom. 6 For the prevention and treatment of sudda in majari (atherosclerosis), the eminent Unani physician-Avicenna advised Istifragh-i-madda i.e. excretion of matter causing obstruction. The obstruction can be evacuated by two means-one by making the ghaleez/thick akhlat thin and other by making lesdar and luzuj/viscous matter less viscous i.e. reducing its viscosity. For the release of akhlat-e-ghaleeza(Vicid Humor) -Mulattifat (demulscent), Muhallilat(resolvent), & Mufatteh sudud (Deobstruent) drugs are to be used that resolves thick humors into thin so that the raddi akhlat, producing obstruction can be easily washed out from the arteries. For lesdar and luzuj/viscous matter, the viscosity can be reduced by the use of Jali(detergent) and Muqatt-e-at, that not only liquefies the madda ( decreasing its viscosity) but also breaks them into small pieces so that it can be easily expel out of the vessels. 40 In Tibbe Unani Aabresham(B.mori) is reported as Mulattif(demulscent), Muhallil(resolvent), Mufattite sudud(deobstruent), Muqatteh, Musaffie dam(blood purifier), Munaqqie balgham wa sauda( Expulsion of phlegm and black bile), Muqawwie jigger wa maida (Stomachic and liver tonic),Mufarrah wa Muqawwie qalb, rooh and azae raeesa (Exhilarant & toni(c for heart and other vital organs). 7, 8, 9, 10, 11 Aabresham(B.mori) by virtue of its resolving and demulscent properties resolve thick and viscous humors. It"s Muqatteh, deobstruent and blood purifying effect breaks akhlate luzuja (Plaques forming matter) in small pieces which are then evacuated from the vessels by its munaqqie balgham and sauda property. Thus, facilitates smooth flow of humors, that strengthen and tafreeh the qalb, rooh, and azae raeesa(exhilarate and strengthens the heart and other vital organs). Its Muqawwie maida wa jigger (Stomachic and liver tonic) activities strengthen and improve the quwwate tabiyah(natural faculties) thereby produces the akhlate saleh i.e. reduces the total cholesterol. Hence, the mechanism proposed by the Unani physicians appears to be comprehensive and very much in proportion with the modern approach of prevention.
The above discussion pointed Aabresham(B.mori) as a promising anti-atherogenic and cardio protective drug still needs further evaluation on large sample size.
Control group
Atorvastatin was used as a standard control drug in this study. Atorvastatin is a member of well known drugStatins, used for lowering blood cholesterol that works by inhibiting Hydroxymethyl glutaryl co-enzyme A (HMG-CoA) reductase, an enzyme found in liver tissue that plays a key role in the production of cholesterol in body. It also acts as anti inflammatory thereby stabilizes the plaque and prevents stroke. 41 Control group equally exhibited significant reduction in palpitation, breathlessness, headache, chest pain, blood pressure, total serum cholesterol, LDL, and MDA concentration after intervention as do the test group.
Conclusion:
The overall effect of Aabresham (B.mori) was found quite encouraging in the atherosclerosis risk group. The efficacy of Aabresham (B.mori) was observed equal to the standard drug i.e. Atorvastatin in reducing palpitation, breathlessness, chest pain, blood pressure, total serum cholesterol, LDL and MDA concentration. The findings outlined above are due to the potent antioxidant, anti inflammatory, anti arrhythmic, anti angiogenic, anti thrombotic, anti coagulant, anti hypertensive, cholesterol and LDL lowering effects of Aabresham(B.mori). All these effects illustrate that the use of Aabresham(B.mori) potentially inhibit the development and rate of progression of atherosclerosis. It is suggestive to intercalate the treatment modalities like weight management, dietary modification and increased physical activity along with Aabresham (B.mori). 
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